Fate of nominees for top EU body remains in doubt
Article Abstract:
The European Parliament is threatening to reject President Jose Manuel Barroso's nominations to the European Commission. The Parliament is specifically objecting to the nominations of Rocco Buttiglione as Justice Commissioner and Neelie Kroes as antitrust chief. The concern with Buttiglione has to do with his views on such social issues as women's rights and homosexuality. With Kroes, Parliament is concerned about potential conflicts of interest between her business ties and her role as a regulator. The Parliament must approve all or none of the nominees.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
China, EU sign copyright-enforcement pact: Beijing will fight piracy but it rebuffs demands to cut tariffs on imports
Article Abstract:
After meeting with European Union trade commissioner Peter Mandelson, Chinese Commerce Minister Bo Xilai has agreed to improve copyright protection. However, Mr. Bo has rejected the European Union's efforts to contain its increasing trade deficit with China by cutting tariffs.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Optimal ordering and pricing policies in a single-period environment with multivariate demand markdowns. Scheduling sports competitions on multiple venues
- Abstracts: Vaunted German engineers face competition from China. Nokia chief sees opening in China: market expands, matures, creating opportunities to sell array of cellphones
- Abstracts: Japan's breakup of Postal System clears big hurdle. Germany, in shift, plans to cut rate of corporate taxes. Foreign funds face tax men in Asia: South Korea, Japan claim abuses of treaties intended to encourage investments
- Abstracts: Bayer forms alliance with Schering-Plough. . Watson Pharmaceuticals to buy rival generic-drug firm Andrx. Vioxx lawsuits may focus on FDA warning in 2001
- Abstracts: Time for a reality check: for us and the TV property experts. Time for a reality check as we seek to invent the future